London, UK (PRWEB) September 09, 2013
In 2010, the total revenue generated by the European in vitro diagnostic (IVD) industry was around EUR 10.5 billion. In the same year, cardiology testing and diabetes segments witnessed the largest growth. Furthermore, considerable double-digit growth was recorded in the sphere pertaining to the management of hospital acquired infections (HAIs).
Germany leads the European IVD reagents market; the value of the country’s market exceeded EUR 2.1 billion in 2010. It is followed by France, Italy, Spain and the UK. However, the highest growth rate (over 6%) was registered in the UK. Rafer, Launch Diagnostics Limited and Bergman Diagnostika AS are amid the leading distributors of IVD reagents, instruments and accessories in Europe.
Insightful research study “The Top 100 Distributors Of IVD Reagents, Instruments & Accessories In Europe” worked out by Research Facts has been recently published by Market Publishers Ltd.
Title: The Top 100 Distributors Of IVD Reagents, Instruments & Accessories In Europe
Published: March, 2013
Price: US$ 1,390.00
The report draws up a clear picture of the competitive scenario in the European IVD reagent market by providing comprehensive profiles of the top 100 distributors of IVD reagents, instruments and accessories. Each company profile include: a company general overview, contact details, data on the key company decision makers and employees, review of the product portfolio and other important information.
The profiled distributors are located in Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Iceland, Ireland, Italy, Malta, Norway, Portugal, Spain, Sweden, Switzerland, the Netherlands and the UK.
Reasons to Buy:
More topical research reports by Research Facts can be found at http://marketpublishers.com/members/research_facts/info.html.
MarketPublishers.com is a multilingual hypermarket offering a rich collection of comprehensive studies on various markets, sectors, industries, companies, etc. We perform professional services aimed to equip our clients with high-quality research products and support critical decision-making.